Institutional Ownership
Oric Pharmaceuticals Inc
CUSIP 68622P109COMORICQ1 2026
13D / 13G Filings
61
Schedule 13D/13G on record
Beneficial Filers
21
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
175
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
61 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 5.8% | 5.68M | SEC |
| 2 | Jan 21, 2026 | Blackrock, Inc. | 13G | 5.6% | 5.47M | SEC |
| 3 | Nov 17, 2025 | The Column Group II, LP | 13G/A | 3.7% | 3.64M | SEC |
| 4 | Nov 13, 2025 | Alkeon Capital Management LLC | 13G/A | 4.6% | 4.50M | SEC |
| 5 | Aug 14, 2025 | Nextech Crossover I Gp S.A. R.L. | 13G/A | 8.4% | 7.16M | SEC |
| 6 | Aug 14, 2025 | Sr One Capital Management, LLC | 13D/A | 4.8% | — | SEC |
| 7 | Aug 14, 2025 | Viking Global Investors LP | 13G/A | 10.0% | 8.73M | SEC |
| 8 | Aug 5, 2025 | Ecor1 Capital, LLC | 13G | 6.9% | — | SEC |
| 9 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 4.2% | 3.62M | SEC |
| 10 | Jun 5, 2025 | Sr One Capital Management, LLC | 13D | 5.4% | — | SEC |
51 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Oric Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nextech Invest, Ltd. | 7.16M | $90.75M |
| 2 | Ecor1 Capital, LLC | 6.73M | $85.25M |
| 3 | Blackrock, Inc. | 5.98M | $75.82M |
| 4 | Viking Global Investors LP | 5.82M | $73.80M |
| 5 | Sr One Capital Management, LP | 4.51M | $58.48M |
| 6 | Pfizer Inc | 4.78M | $57.65M |
| 7 | Alkeon Capital Management LLC | 4.50M | $57.07M |
| 8 | Venrock Adviser, LLC | 4.32M | $54.73M |
| 9 | Nea Management Company, LLC | 4.12M | $52.18M |
| 10 | State Street Corp | 3.70M | $46.91M |